Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02105324 · ClinicalTrials.gov registry record · NA
The Summer Camp Study 2: Blood Glucose Control With a Bi-Hormonal Endocrine Pancreas
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT02105324: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02105324 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02105324, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study will test the hypothesis that a wearable automated bionic pancreas system that automatically delivers both insulin and glucagon can improve glycemic control vs. usual care for young people with type 1 diabetes ages 6-11 years old in a diabetes camp environment.
Interventions
- OTHER Usual Care
- DEVICE Bionic Pancreas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2014-06 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02105324
The ClinicalTrials.gov registry entry for NCT02105324 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT02105324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02105324 about?
NCT02105324 is a clinical study titled "The Summer Camp Study 2: Blood Glucose Control With a Bi-Hormonal Endocrine Pancreas". This study will test the hypothesis that a wearable automated bionic pancreas system that automatically delivers both insulin and glucagon can improve glycemic control vs. usual care for young people with type 1 diabetes ages 6-11 years old in a diabetes camp environment.
What is the current status of trial NCT02105324?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2014-06. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02105324?
The interventions under investigation include: Usual Care (OTHER), Bionic Pancreas (DEVICE).
Who is sponsoring clinical trial NCT02105324?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.